HKU Scholars Hub: Browsing DSpace

Browsing by Author Afdhal, NH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date
	A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naive patients with chronic hepatitis B Journal:Liver International	Yuen, MF Chen, CY Liu, CJ Jeng, WJ Elkhashab, M Coffin, CS Kim, W Greenbloom, S Ramji, A Lim, YS Kim, YJ Fung, SK Kim, DJ Jang, JW Lee, KS Iyer, RP Macfarlane, C Jackson, K Locarnini, SA Chan, HLY Afdhal, NH	11-Nov-2022
	Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response Proceeding/Conference:Hepatology	Yuen, RMF Elkhashab, M Chen, CY Chen, YF Coffin, CS Fung, SK Greenbloom, S Jang, JW Jeng, WJ Kim, DJ Kim, YJ Kim, W Lee, KS Lim, YS Liu, CJ Ramji, A Iyer, R Macfarlane, C Jackson, K Locarnini, S Afdhal, NH Chan, HLY ACHIEVE STUDY Investigators,	2018
	Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology	Locarnini, S Wong, DKH Jackson, K Walsh, R Edwards, R Hammond, R Macfarlane, C Iyer, RP Afdhal, NH Yuen, RMF	2017
	SB 9200 an oral selective immunomodulator is safe and efficacious in treatment-naive, non-cirrhotic HBV patients: Results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology	Yuen, RMF Coffin, CS Elkhashab, M Greenbloom, S Ramji, A Chan, HLY Iyer, RP Locarnini, S Macfarlane, C Afdhal, NH Kim, W	2017

Showing results 1 to 4 of 4